Vireo Growth Inc. operates as a cannabis company which cultivates, manufactures, processes and distributes medical and adult-use cannabis products principally in Maryland, Minnesota and New York. Vireo Growth Inc. is based in Minneapolis, Minnesota.
| Revenue (Most Recent Fiscal Year) | $268.77M |
| Net Income (Most Recent Fiscal Year) | $-68.11M |
| PE Ratio (Current Year Earnings Estimate) | 13.70 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.52 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.45 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -14.85% |
| Net Margin (Trailing 12 Months) | -25.28% |
| Return on Equity (Trailing 12 Months) | -18.31% |
| Return on Assets (Trailing 12 Months) | -6.57% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.59 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.28 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.44 |
| Inventory Turnover (Trailing 12 Months) | 2.83 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.90 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.01 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.06 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.11 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 339.75M |
| Free Float | 315.29M |
| Market Capitalization | $139.60M |
| Average Volume (Last 20 Days) | 0.25M |
| Beta (Past 60 Months) | -- |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 7.20% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |